Baikang Bio
Nanjing
About Baikang Bio
Baikang Bio is a tech biotechnology firm specializing in the research and development of antigens, antibodies, and downstream detection reagents for diagnosis and therapy. The product pipelines cover cardiovascular and cerebrovascular, inflammation, infectious diseases, tumors, hormones, and other categories, from raw materials to finished goods. They are dedicated to innovation and providing their customers with solutions. They could contribute to human ecology and health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $13.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: bioantibody.com.cn
- Phone: 025-5850-1988
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/baikang-bio-137644 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.